A recombinant non-toxigenic Clostridioides difficile spore vaccine directed against toxigenic C. difficile
Clostridioides difficile (C. difficile) is the leading cause of hospital acquired diarrhoeal infection. Its pathology is mainly due to two toxins, TcdA and TcdB. The failure to treat recurrent infection can culminate in death and thus preventative measures are of urgent need. Current vaccine trials...
| Main Author: | Aston, Carl |
|---|---|
| Format: | Thesis (University of Nottingham only) |
| Language: | English |
| Published: |
2022
|
| Subjects: | |
| Online Access: | https://eprints.nottingham.ac.uk/69093/ |
Similar Items
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021)
by: Karyal, Cansu
Published: (2021)
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023)
by: Wood, Liam
Published: (2023)
Identification and characterisation of novel bacteriocins active against Clostridioides difficile
by: Chapman, Sarah May Olivia
Published: (2020)
by: Chapman, Sarah May Olivia
Published: (2020)
Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024)
by: von Emloh, Louise
Published: (2024)
Spore germination and recurrence of clostridioides difficile infection
by: Finch, Lorna
Published: (2020)
by: Finch, Lorna
Published: (2020)
DNA arrays, electronic noses and tongues, biosensors and receptors for rapid detection of toxigenic fungi and mycotoxins: A review
by: Logrieco, A., et al.
Published: (2005)
by: Logrieco, A., et al.
Published: (2005)
Towards development of a liposome-based vaccine to combat Clostridium difficile infection
by: Palazi, Panayiota
Published: (2021)
by: Palazi, Panayiota
Published: (2021)
Exposing hidden putative lipoproteins in Clostridium difficile
by: Griffin, R., et al.
Published: (2017)
by: Griffin, R., et al.
Published: (2017)
Transposon mutagenesis in RT 078 Clostridioides difficile
by: te Vrugt, Marcel
Published: (2023)
by: te Vrugt, Marcel
Published: (2023)
Towards safe and stable Clostridium botulinum strains for research and industrial applications
by: Groothuis, Daphne
Published: (2022)
by: Groothuis, Daphne
Published: (2022)
Obtaining a lytic bacteriophage suitable for use in phage therapy against Clostridioides difficile infection
by: Kerr, Sarah
Published: (2023)
by: Kerr, Sarah
Published: (2023)
Analysis of the spore germination mechanisms of Clostridium difficile
by: Burns, David Alexander
Published: (2011)
by: Burns, David Alexander
Published: (2011)
Isolation and molecular characterization of mycotoxigenic fungi from Palm Kernel Cake and effects of temperature on aflatoxin production
by: Razali, Siti Mardhiyah
Published: (2016)
by: Razali, Siti Mardhiyah
Published: (2016)
High prevalence of subclass-specific binding and neutralizing antibodies against Clostridium difficile toxins in adult cystic fibrosis sera: possible mode of immunoprotection against symptomatic C. difficile infection
by: Monaghan, Tanya M., et al.
Published: (2017)
by: Monaghan, Tanya M., et al.
Published: (2017)
Occurrence of mycotoxigenic fungi and multi-mycotoxin contamination in corn-based poultry feed supply chain
by: Nasaruddin, Norafidah
Published: (2020)
by: Nasaruddin, Norafidah
Published: (2020)
The clinical and environmental spread and diversity of toxigenic Clostridium difficile diarrhea in the region of the Middle East.
by: N., Sadeghifard, et al.
Published: (2010)
by: N., Sadeghifard, et al.
Published: (2010)
Amino acids utilisation by Clostridium difficile strains
by: Ogbu, H.I.
Published: (2016)
by: Ogbu, H.I.
Published: (2016)
Both, toxin A and toxin B, are important in Clostridium difficile infection
by: Kuehne, Sarah A., et al.
Published: (2011)
by: Kuehne, Sarah A., et al.
Published: (2011)
Identification and characterisation of tail components modulating host range of Clostridium difficile phages
by: Steczynska, Joanna
Published: (2023)
by: Steczynska, Joanna
Published: (2023)
Protective antibodies against Clostridium difficile are present in intravenous immunoglobulin and are retained in humans following its administration
by: Negm, Ola H., et al.
Published: (2017)
by: Negm, Ola H., et al.
Published: (2017)
Identification and characterisation of potential bacteriocins with biological activity against Clostridium difficile from environmental samples
by: Kim, Sungchan
Published: (2018)
by: Kim, Sungchan
Published: (2018)
Profiling humoral immune responses to Clostridium difficile-specific antigens by protein microarray analysis
by: Negm, Ola H., et al.
Published: (2015)
by: Negm, Ola H., et al.
Published: (2015)
The antimicrobial and bile acid mediated control of
Clostridium difficile infection
by: Dempster, Andrew William
Published: (2018)
by: Dempster, Andrew William
Published: (2018)
Mucosal cell responses to Clostridium difficile toxins
by: Mullan, Nivette K.
Published: (2011)
by: Mullan, Nivette K.
Published: (2011)
Understanding certain Clostridium difficile virulence and antibiotic resistance factors and how these relate to patient clinical outcome
by: Kinsmore, Natasha Louise
Published: (2019)
by: Kinsmore, Natasha Louise
Published: (2019)
CdtR-mediated regulation of toxin production in Clostridium difficile
by: Bilverstone, Terry W.
Published: (2019)
by: Bilverstone, Terry W.
Published: (2019)
Isolation and characterisation of four novel bacteriophages infecting clinically relevant PCR ribotypes of Clostridium difficile
by: Whittle, Michaella
Published: (2018)
by: Whittle, Michaella
Published: (2018)
Importance of Toxin A, Toxin B, and CDT in virulence of an epidemic Clostridium difficile strain
by: Kuehne, Sarah A., et al.
Published: (2013)
by: Kuehne, Sarah A., et al.
Published: (2013)
A protein microarray assay for serological determination of antigen-specific antibody responses following Clostridium difficile infection
by: Negm, Ola H., et al.
Published: (2018)
by: Negm, Ola H., et al.
Published: (2018)
Investigation of the effect of insertional mutation in agr and sigB loci in Clostridium difficile R20291
by: Montfort-Gardeazabal, Jorge M.
Published: (2017)
by: Montfort-Gardeazabal, Jorge M.
Published: (2017)
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in bile acid-farnesoid X receptor-fibroblast growth factor pathway
by: Monaghan, Tanya M., et al.
Published: (2018)
by: Monaghan, Tanya M., et al.
Published: (2018)
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
by: van Eijk, Erika, et al.
Published: (2016)
by: van Eijk, Erika, et al.
Published: (2016)
Primase is required for helicase activity and helicase alters the specificity of primase in the enteropathogen Clostridium difficile
by: van Eijk, Erika, et al.
Published: (2016)
by: van Eijk, Erika, et al.
Published: (2016)
Reduction of antimicrobial resistance through antimicrobial stewardship
by: Saxby, Claire F.
Published: (2020)
by: Saxby, Claire F.
Published: (2020)
A race for a better understanding of COVID-19 vaccine non-adopters
by: Su, Zhaohui, et al.
Published: (2020)
by: Su, Zhaohui, et al.
Published: (2020)
Evaluation of the detection techniques of toxigenic Aspergillus isolates
by: Darab, Yazdani, et al.
Published: (2010)
by: Darab, Yazdani, et al.
Published: (2010)
Development of Clostridium difficile R20291ΔPaLoc model strains and in vitro methodologies reveals CdtR is required for the production of CDT to cytotoxic levels
by: Bilverstone, T.W., et al.
Published: (2017)
by: Bilverstone, T.W., et al.
Published: (2017)
Spores of Clostridium difficile clinical isolates display a diverse germination response to bile salts
by: Heeg, Daniela, et al.
Published: (2012)
by: Heeg, Daniela, et al.
Published: (2012)
Toxigenic Campylobacter jejuni in vegetables farms and retail outlets in Terengganu
by: Tang, John Yew Huat, et al.
Published: (2017)
by: Tang, John Yew Huat, et al.
Published: (2017)
Immunological responses toward caseous lymphadenitis recombinant vaccine incorporated with different adjuvants
by: Md Nor, Roslindawani
Published: (2018)
by: Md Nor, Roslindawani
Published: (2018)
Similar Items
-
Development of an oral vaccine against Clostridioides difficile
by: Karyal, Cansu
Published: (2021) -
Developing a protein subunit oral vaccine against Clostridioides difficile
by: Wood, Liam
Published: (2023) -
Identification and characterisation of novel bacteriocins active against Clostridioides difficile
by: Chapman, Sarah May Olivia
Published: (2020) -
Investigating the bile acid mediated control of Clostridioides difficile infection
by: von Emloh, Louise
Published: (2024) -
Spore germination and recurrence of clostridioides difficile infection
by: Finch, Lorna
Published: (2020)